Wahl R - Search Results

1

[18F]fluorodeoxyglucose positron emission tomography correlates with Akt pathway activity but is not predictive of clinical outcome during mTOR inhibitor therapy.

Ma WW, Jacene H, Song D, Vilardell F, Messersmith WA, Laheru D, Wahl R, Endres C, Jimeno A, Pomper MG, Hidalgo M. Ma WW, et al. Among authors: wahl r. J Clin Oncol. 2009 Jun 1;27(16):2697-704. doi: 10.1200/JCO.2008.18.8383. Epub 2009 Apr 20. J Clin Oncol. 2009. PMID: 19380450 Free PMC article. Clinical Trial.

2

Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation.

Wahl RL, Zasadny K, Helvie M, Hutchins GD, Weber B, Cody R. Wahl RL, et al. J Clin Oncol. 1993 Nov;11(11):2101-11. doi: 10.1200/JCO.1993.11.11.2101. J Clin Oncol. 1993. PMID: 8229124

3

Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy.

Sugawara Y, Fisher SJ, Zasadny KR, Kison PV, Baker LH, Wahl RL. Sugawara Y, et al. Among authors: wahl rl. J Clin Oncol. 1998 Jan;16(1):173-80. doi: 10.1200/JCO.1998.16.1.173. J Clin Oncol. 1998. PMID: 9440740

4

Prospective evaluation of 2-[18F]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma.

Macfarlane DJ, Sondak V, Johnson T, Wahl RL. Macfarlane DJ, et al. Among authors: wahl rl. J Clin Oncol. 1998 May;16(5):1770-6. doi: 10.1200/JCO.1998.16.5.1770. J Clin Oncol. 1998. PMID: 9586890

5

Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET Study Group.

Wahl RL, Siegel BA, Coleman RE, Gatsonis CG; PET Study Group. Wahl RL, et al. J Clin Oncol. 2004 Jan 15;22(2):277-85. doi: 10.1200/JCO.2004.04.148. J Clin Oncol. 2004. PMID: 14722036 Clinical Trial.

6

F-18 FDG PET/CT in acute respiratory distress syndrome: a case report.

Jacene HA, Cohade C, Wahl RL. Jacene HA, et al. Clin Nucl Med. 2004 Dec;29(12):786-8. doi: 10.1097/00003072-200412000-00002. Clin Nucl Med. 2004. PMID: 15545878

7

Combined FDG-positron emission tomography and computed tomography for the detection of ovarian cancer recurrence in an inguinal hernia sac.

Díaz-Montes TP, Jacene HA, Wahl RL, Bristow RE. Díaz-Montes TP, et al. Gynecol Oncol. 2005 Sep;98(3):510-2. doi: 10.1016/j.ygyno.2005.05.008. Gynecol Oncol. 2005. PMID: 15992914

8

Imaging of pelvic malignancies with in-line FDG PET-CT: case examples and common pitfalls of FDG PET.

Subhas N, Patel PV, Pannu HK, Jacene HA, Fishman EK, Wahl RL. Subhas N, et al. Radiographics. 2005 Jul-Aug;25(4):1031-43. doi: 10.1148/rg.254045155. Radiographics. 2005. PMID: 16009822 Review.

9

The role of positron emission tomography and computed tomography fusion in the management of early-stage and advanced-stage primary head and neck squamous cell carcinoma.

Ha PK, Hdeib A, Goldenberg D, Jacene H, Patel P, Koch W, Califano J, Cummings CW, Flint PW, Wahl R, Tufano RP. Ha PK, et al. Among authors: wahl r. Arch Otolaryngol Head Neck Surg. 2006 Jan;132(1):12-6. doi: 10.1001/archotol.132.1.12. Arch Otolaryngol Head Neck Surg. 2006. PMID: 16415423

10

Effects of pegfilgrastim on normal biodistribution of 18F-FDG: preclinical and clinical studies.

Jacene HA, Ishimori T, Engles JM, Leboulleux S, Stearns V, Wahl RL. Jacene HA, et al. J Nucl Med. 2006 Jun;47(6):950-6. J Nucl Med. 2006. PMID: 16741304 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

985 results

Search Page